NO20083584L - Bensoyl-piperidin derivater som 5HT2/D3 modulatorer - Google Patents

Bensoyl-piperidin derivater som 5HT2/D3 modulatorer

Info

Publication number
NO20083584L
NO20083584L NO20083584A NO20083584A NO20083584L NO 20083584 L NO20083584 L NO 20083584L NO 20083584 A NO20083584 A NO 20083584A NO 20083584 A NO20083584 A NO 20083584A NO 20083584 L NO20083584 L NO 20083584L
Authority
NO
Norway
Prior art keywords
modulators
benzoyl
piperidine derivatives
ht2a
compounds
Prior art date
Application number
NO20083584A
Other languages
English (en)
Inventor
Luca Claudio Gobbi
Thomas Luebbers
Olivier Roche
Georg Jaeschke
Rosa Maria Rodriguez Sarmiento
Lucinda Steward
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38091740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20083584(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20083584L publication Critical patent/NO20083584L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser med den generelle formel som doble modulatorer av 5-HT2a- og D3-reseptorer som er anvendelige mot CNS-lidelser, hvor A, R1, R2, n, p, q og r er som definert i beskrivelsen. 1
NO20083584A 2006-02-17 2008-08-19 Bensoyl-piperidin derivater som 5HT2/D3 modulatorer NO20083584L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06110112 2006-02-17
EP06112464 2006-04-11
PCT/EP2007/051160 WO2007093540A1 (en) 2006-02-17 2007-02-07 Benzoyl-piperidine derivatives as 5ht2/d3 modulators

Publications (1)

Publication Number Publication Date
NO20083584L true NO20083584L (no) 2008-11-14

Family

ID=38091740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083584A NO20083584L (no) 2006-02-17 2008-08-19 Bensoyl-piperidin derivater som 5HT2/D3 modulatorer

Country Status (15)

Country Link
US (2) US8039490B2 (no)
EP (1) EP1987019B1 (no)
JP (1) JP4855485B2 (no)
KR (1) KR101062513B1 (no)
AR (1) AR059513A1 (no)
AU (1) AU2007216563B2 (no)
BR (1) BRPI0707960A2 (no)
CA (1) CA2640807A1 (no)
CL (1) CL2007000396A1 (no)
ES (1) ES2399447T3 (no)
IL (1) IL193176A (no)
NO (1) NO20083584L (no)
RU (1) RU2396265C2 (no)
TW (1) TWI329107B (no)
WO (1) WO2007093540A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5502733B2 (ja) * 2007-07-26 2014-05-28 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ２ａ及びｄ３受容体の二重のモジュレーター
JP5296073B2 (ja) * 2007-08-09 2013-09-25 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ２ａ及びｄ３受容体のデュアルモジュレーターとしてのベンゾイル−ピペリジン誘導体
KR101329548B1 (ko) 2008-09-22 2013-11-18 에프. 호프만-라 로슈 아게 피페라진 ｄ3 및 5-ｈｔ2ａ 수용체 조절제
US8586579B2 (en) 2010-06-21 2013-11-19 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8470828B2 (en) 2010-07-06 2013-06-25 Hoffmann-La Roche Inc. Anellated pyridine compounds
RU2013126657A (ru) * 2010-11-15 2014-12-27 Эббви Инк. Ингибиторы nampt и rock
US8877778B2 (en) * 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
US8722683B2 (en) 2011-02-17 2014-05-13 Hoffmann La-Roche Inc. Benzodioxole piperazine compounds
US8598357B2 (en) 2011-03-03 2013-12-03 Hoffmann-La Roche Inc. Benzodioxole piperidine compounds
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds
CN107847495A (zh) * 2015-05-06 2018-03-27 加利福尼亚大学董事会 K‑Ras调节剂
US11358940B2 (en) 2017-04-20 2022-06-14 The Regents Of The University Of California K-Ras modulators
JP6948830B2 (ja) * 2017-05-17 2021-10-13 花王株式会社 乳化化粧料
KR102656934B1 (ko) 2017-07-10 2024-04-16 셀진 코포레이션 항증식성 화합물 및 이의 사용 방법
BR112022007238A2 (pt) 2019-10-29 2022-07-05 Shanghai Hansoh Biomedical Co Ltd Compostos modificadores derivados de anel de quatro membros, métodos para preparar os referidos compostos, composição e uso
TW202118758A (zh) 2019-11-05 2021-05-16 大陸商上海翰森生物醫藥科技有限公司 苯并噻吩類衍生物調節劑、其製備方法和應用
WO2021164661A1 (zh) * 2020-02-20 2021-08-26 上海科技大学 2-苯基环丙基甲基胺衍生物及其制备方法和用途
KR20240005786A (ko) 2021-04-28 2024-01-12 상하이 한서 바이오메디컬 컴퍼니 리미티드 피페라진 폴리사이클릭 유도체를 함유하는 염, 이의 결정형, 이의 제조 방법, 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024264A (en) * 1974-08-15 1977-05-17 Ab Ferrosan Diphenylbutylpiperidines
GB1514718A (en) 1974-08-15 1978-06-21 Ferrosan Ab Diphenyl-butylpiperidines
JP2860689B2 (ja) * 1990-03-14 1999-02-24 第一製薬株式会社 ピリミジン誘導体
EP0479601B1 (en) * 1990-10-05 1999-12-15 Ajinomoto Co., Inc. Piperidine derivatives and their use as antiarrhythmic agents
CZ20013451A3 (cs) 1999-03-26 2002-04-17 Astrazeneca Ab Nové sloučeniny
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
HUP0103986A2 (hu) * 2001-09-28 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Új karbonsavamid szerkezetet tartalmazó piperidinil vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CA2473892C (en) * 2001-12-04 2010-09-21 Actelion Pharmaceuticals Ltd Novel quinoline derivatives
EP1348434A1 (en) * 2002-03-27 2003-10-01 Fujisawa Deutschland GmbH Use of pyridyl amides as inhibitors of angiogenesis
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
AU2003303678A1 (en) 2003-01-03 2004-08-10 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
JP5502733B2 (ja) * 2007-07-26 2014-05-28 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ２ａ及びｄ３受容体の二重のモジュレーター
JP5296073B2 (ja) * 2007-08-09 2013-09-25 エフ．ホフマン−ラ ロシュ アーゲー ５−ｈｔ２ａ及びｄ３受容体のデュアルモジュレーターとしてのベンゾイル−ピペリジン誘導体

Also Published As

Publication number Publication date
AU2007216563A1 (en) 2007-08-23
EP1987019A1 (en) 2008-11-05
US20120004208A1 (en) 2012-01-05
IL193176A (en) 2013-01-31
JP2009526807A (ja) 2009-07-23
RU2396265C2 (ru) 2010-08-10
TWI329107B (en) 2010-08-21
WO2007093540A1 (en) 2007-08-23
IL193176A0 (en) 2009-02-11
RU2008133322A (ru) 2010-03-27
EP1987019B1 (en) 2012-11-28
US20070197531A1 (en) 2007-08-23
US8039490B2 (en) 2011-10-18
KR101062513B1 (ko) 2011-09-06
ES2399447T3 (es) 2013-04-01
JP4855485B2 (ja) 2012-01-18
CA2640807A1 (en) 2007-08-23
KR20080095899A (ko) 2008-10-29
TW200808758A (en) 2008-02-16
US8415350B2 (en) 2013-04-09
AR059513A1 (es) 2008-04-09
AU2007216563B2 (en) 2012-08-09
CL2007000396A1 (es) 2008-01-04
BRPI0707960A2 (pt) 2011-05-10

Similar Documents

Publication Publication Date Title
NO20083584L (no) Bensoyl-piperidin derivater som 5HT2/D3 modulatorer
NO20084783L (no) Syntese av acylaminoalkenylenamider nyttige som substans P antagonister
EA200702470A1 (ru) Производные пиррола в качестве положительных аллостерических модуляторов метаботропных глутаматных рецепторов
ATE463495T1 (de) Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten
MX2009003316A (es) Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
IL189191A0 (en) Thiazolyl piperidine derivatives useful as h3 receptor modulators
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
NO20093200L (no) Tiazolidinderivater
NO20076479L (no) Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
ATE493397T1 (de) Neuartige tetrazolderivate als positive allosterische modulatoren von metabotropen glutamatrezeptoren
ATE524466T1 (de) 3-azabicycloä3.3.0üoktanverbindungen
NO20076478L (no) Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
NO20065733L (no) Naftalinderivater nyttige som histamin-3-reseptor ligander
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20071922L (no) Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
TW200738651A (en) Cyclohexyl sulfonamide derivatives
MX2010004272A (es) Derivados de tetrazol como moduladores de receptores de glutamato metabotropicos (mglurs).
NO20090779L (no) 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA200701817A1 (ru) Новые соли 6-гетероциклических замещенных производных гексагидрофенантридина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application